Uptake Medical
2028 5th Avenue
Suite 204
Seattle
Washington
98121
United States
Tel: 206-859-4555
Fax: 206-859-4557
Website: http://www.uptakemedical.com/
Email: info@uptakemedical.com
18 articles about Uptake Medical
-
Uptake Medical Release: InterVapor Bronchoscopic Thermal Vapor Ablation (BTVA) Is Back On The Market
9/7/2017
-
Uptake Medical Release: Intervapor Targeted Ablation Therapy Reported As Superior To Standard Medical Management In The Lancet
3/1/2016
-
Uptake Medical Announces First-In-Human Lung Cancer Tumor Ablation Using Intervapor Targeted Vapor Therapy
10/12/2015
-
Data Confirms Uptake Medical’s InterVapor Significantly Improves Lung Function in Severe Emphysema Patients
10/2/2015
-
Uptake Medical Receives CE Mark Approval For InterVapor Targeted Ablation Therapy For Severe Emphysema
8/12/2015
-
Uptake Medical Announces Positive 12-month Outcome Data for InterVapor Therapy for Severe Emphysema
5/24/2012
-
Uptake Medical Announces Successful Completion of Series C Financing
1/9/2012
-
Uptake Medical Raises $35 Million Cash for Novel Emphysema Treatment
1/4/2012
-
Uptake Medical Announces TGA Approval of InterVapor for Patients With Severe Emphysema
12/21/2011
-
Uptake Medical Announces First Commercial Use of InterVapor for Patients With Severe Emphysema
11/29/2011
-
Uptake Medical Receives CE Mark for InterVapor - Endoscopic Lung Volume Reduction for Treatment of Severe Emphysema - and Announces Positive Clinical Results
9/26/2011
-
Uptake Medical Expands Executive Team, Announces European General Manager Lloyd Mencinger
9/6/2011
-
Uptake Medical Announces Scott Huennekens Elected to Board of Directors
3/1/2011
-
Uptake Medical Ups and Goes to the O.C., Retains Technical Center in Seattle
1/31/2011
-
Uptake Medical Names J.C. MacRae as Chief Financial Officer
11/16/2010
-
Steven Kesten, M.D., Leader in Pulmonary Medicine, Joins Uptake Medical as Vice President and Chief Medical Officer
11/1/2010
-
Uptake Medical Completes Series B Financing Round for $17.5 Million
7/7/2010
-
Uptake Medical Nabs $3.4 Million
9/14/2009